Europe gets Amgen cholesterol drug for 50-60 pct of U.S. price

LONDON, Sept 1 (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.